Pharmaceutical Executive
As payers increasingly stifle new drug launches, investors in biopharmaceutical companies pursue better sources of insights.
Nora Tsivgas
Advertisement
Articles by Nora Tsivgas
Advertisement
Latest Updated Articles
For Payer Research, High Stakes are the Mother of All InventionOctober 4th 2019
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials
5